A bipartisan group of senators Aug. 5 introduced the Supporting Underserved and Strengthening Transparency, Accountability ...

The Health Resources and Services Administration is again pushing to include rebates in the drug discount program after a failed attempt earlier this year. Hospitals railed against the announcement, ...

After years of bipartisan deliberation, U.S. Sen. Tim Kaine, D-Va., has introduced legislation to strengthen and protect a federal drug pricing program. Known as 340B, the program has helped Virginia ...

The Health Resources and Services Administration (HRSA) announced that it is moving forward with a revised 340B rebate pilot that would allow qualifying drug manufacturers to provide post-purchase ...

​A fight over an embattled drug discount program is intensifying on Capitol Hill, as lawmakers weigh competing proposals to ...

HealthTrust Performance Group ™ (HealthTrust) hosted its third annual 340B Summit in Denver from July 22-23, 2026, to help members navigate the evolving 340B Drug Pricing Program, in its efforts to ...

Forbes contributors publish independent expert analyses and insights. Anthony T. Lo Sasso is Professor of Public Affairs at UW-Madison This voice experience is generated by AI. Learn more. This voice ...

On August 3, 2026, the Health Resources and Services Administration (HRSA) published a revised 340B Rebate Pilot Program (the “Pilot Program”) in ...

The Trump administration has revised the terms of a pilot effort that will allow some drugmakers to offer rebates to certain ...

The Department of Health and Human Services today issued a notice announcing a revised 340B Rebate Model Pilot Program, ...

Henry Ford Health has filed a lawsuit against CVS Health (NYSE:CVS) alleging fraudulent reimbursement practices tied to the ...